BI-1815368
- Generic Name
- BI-1815368
A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edema
- First Posted Date
- 2025-05-08
- Last Posted Date
- 2025-05-08
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 300
- Registration Number
- NCT06962839
A Study in Healthy Men to Test Whether BI 1815368 Influences the Amount of Metformin in the Body
- First Posted Date
- 2024-10-23
- Last Posted Date
- 2025-03-05
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 14
- Registration Number
- NCT06655220
- Locations
- 🇩🇪
Humanpharmakologisches Zentrum Biberach, Biberach, Germany
A Study to Test How Different Doses of BI 1815368 Are Tolerated and How BI 1815368 is Taken up in the Body of Healthy Japanese Men
- First Posted Date
- 2024-07-10
- Last Posted Date
- 2025-01-22
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 26
- Registration Number
- NCT06494774
- Locations
- 🇯🇵
SOUSEIKAI Sumida Hospital, Tokyo, Sumida-ku, Japan
A Study in Healthy Men to Test How Itraconazole Influences the Amount of BI 1815368 in the Blood
- First Posted Date
- 2023-07-28
- Last Posted Date
- 2023-11-03
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 14
- Registration Number
- NCT05965583
- Locations
- 🇩🇪
Humanpharmakologisches Zentrum Biberach, Biberach, Germany
A Study to Test How Well Different Doses of BI 1815368 Are Tolerated by Healthy Men
- First Posted Date
- 2023-05-15
- Last Posted Date
- 2024-11-19
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 59
- Registration Number
- NCT05857878
- Locations
- 🇧🇪
SGS Life Science Services - Clinical Research, Edegem, Belgium
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath